After 6 monthly injections ( treatment period ) , patients meeting prespecified criteria received as-needed ( pro re nata [ PRN ] ) ranibizumab at their assigned dose ( sham patients , ranibizumab 0.5 mg ) through month 12 ( observation period ) .